注：#共同第一作者；*通讯作者
[1] Meng K, Li Y, Yuan X, Shen HM, Hu LL, Liu D, Shi F, Zheng D, Shi X, Wen N, Cao Y, Pan YL, He QY*, Zhang CZ*. The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis. Signal Transduct Target Ther 2025 Jan 27;10(1):43.
[2] Lu JL, Ye YL, Zheng DD, Shi XY, Hu LL, Yuan XY, Cai TN, Meng K, Wen NQ, Li YY, Wang DK, Shi FJ, Liu DY, He QY, Qin ZK, Zhang CZ*, Cao Y*. Temporal dynamics of immune cell patterns in bladder cancer patients receiving Bacillus Calmette-Guérin therapy. Br J Cancer. 2024 Dec;131(12):1901-1912.
[3] Hu L, Shi X, Yuan X, Liu D, Zheng D, Li Y, Shi F, Zhang M, Su SG, Zhang CZ*. PPM1G-mediated TBL1X mRNA splicing promotes cell migration in hepatocellular carcinoma. Cancer Sci. 2025 Jan;116(1):67-80.
[4] Zheng DD, Li YY, Yuan XY, Lu JL, Zhang MF, Fu J, Zhang CZ*. Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. BMC Cancer. 2024 May 27;24(1):649.
[5] Hu L, Liu D, Zheng D, Lu J, Yuan X, Li Y, Shi F, Shi X, He QY, Li Q*, Zhang CZ*. Pan-Cancer Proteomics Analysis Reveals Wiskott-Aldrich Syndrome Protein as a Potential Regulator of Programmed Death-Ligand 1. J Proteome Res 2024 Jun 7;23(6):2195-2205.
[6] Wang H, Qian D, Wang J, Liu Y, Luo W, Zhang H, Cheng J, Li H, Wu Y, Li W, Wang J, Yang X, Zhang T, Han D, Wang Q, Zhang CZ*, Liu L*. HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis. J Adv Res 2024, S2090-1232(24)00072-9.
[7] Meng K, Li YY, Liu DY, Hu LL, Pan YL, Zhang CZ*, He QY*. A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma. Comput Struct Biotechnol J 2023, 21:2621-2630.
[8] Meng K, Lu S, Li YY, Hu LL, Zhang J, Cao Y, Wang Y, Zhang CZ*, He QY*. LINC00493-encoded microprotein SMIM26 exerts anti-metastatic activity in renal cell carcinoma. EMBO Rep 2023, 24(6):e56282.
[9] EFHD1, a novel mitochondrial regulator of tumor metastasis in clear cell renal cell carcinoma. Meng K, Hu Y, Wang D, Li Y, Shi F, Lu J, Wang Y, Cao Y, Zhang CZ*, He QY*. Cancer Sci 2023, 114(5):2029-2040.
[10] Lu J, Zhao M, Wu C, Chu C, Zhang CZ*, Cao Y*. Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues. Diagn Pathol 2022, 17(1):10.
[11] Wu CY, Li L, Chen SL, Yang X, Zhang CZ*, Cao Y*. A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma. Cell Death Dis 2021, 12(4):319.
[12] Su SG, Li QL, Zhang MF, Zhang PW, Shen H, Zhang CZ*. An E2F1/DDX11/EZH2 Positive Feedback Loop Promotes Cell Proliferation in Hepatocellular Carcinoma. Front Oncol 2021, 10:593293.
[13] Huang YH#, Zhang CZ#, Huang QS#, Yeong J, Wang F, Yang X, He YF, Zhang XL, Zhang H, Chen SL, Zheng YL, Deng R, Lin CS, Yang MM, Li Y, Jiang C, Kin-Wah Lee T, Ma S, Zeng MS, Yun JP*. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma. J Hepatol 2021, 74(4):838-849.
[14] Zhang MF, Li QL, Yang YF, Cao Y*, Zhang CZ*. FMNL1 Exhibits Pro-Metastatic Activity via CXCR2 in Clear Cell Renal Cell Carcinoma. Front Oncol 2020, 10:564614.
[15] Chu C, Yao K, Lu J, Zhang Y, Chen K, Lu J, Zhang CZ*, Cao Y*. Immunophenotypes Based on the Tumor Immune Microenvironment Allow for Unsupervised Penile Cancer Patient Stratification. Cancers (Basel) 2020, 12(7):1796.
[16] Jiang N, Niu G, Pan YH, Pan W, Zhang MF, Zhang CZ*, Shen H*. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma. EBioMedicine 2020, 53:102692.
[17] Chen SL, Liu LL, Wang CH, Lu SX, Yang X, He YF, Zhang CZ*, Yun JP*. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways. Mol Oncol 2020, 14(2):373-386.
[18] Chen SL#, Zhang CZ#, Liu LL#, Lu SX#, Pan YH, Wang CH, He YF, Lin CS, Yang X, Xie D, Yun JP*. A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma. Cancer Research 2019, 79:534-545.
[19] Wang H#, Zhang CZ#, Lu SX#, Zhang MF#, Liu LL, Luo RZ, Yang X, Wang CH, Chen SL, He YF, Xie D, Xu RH, Yun JP*. A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway. Hepatology 2019, 69:179-195.
[20] Yang YF, Zhang MF, Tian QH, Fu J, Yang X, Zhang CZ*, Yang H*. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Molecular Cancer 2018, 17:117.
[21] Zhang CZ#, Chen SL#, Wang CH#, He YF, Yang X, Xie D, Yun JP*. CBX8 Exhibits Oncogenic Activity via AKT/beta-Catenin Activation in Hepatocellular Carcinoma. Cancer Research 2018, 78:51-63.